These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7560546)

  • 1. A 3-year follow-up of a group of treatment-resistant depressed patients with a MAOI/tricyclic combination.
    Berlanga C; Ortega-Soto HA
    J Affect Disord; 1995 Jun; 34(3):187-92. PubMed ID: 7560546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase inhibitors (MAOI) or reversible inhibitors of monoamine oxidase (RIMA)/tricyclic antidepressant (TCA) combination therapy.
    Tiller JW; Mitchell P; Burrows GD
    Aust N Z J Psychiatry; 1992 Jun; 26(2):327-9. PubMed ID: 1642632
    [No Abstract]   [Full Text] [Related]  

  • 3. Combining tricyclic and monoamine oxidase inhibitor antidepressants.
    Spiker DG; Pugh DD
    Arch Gen Psychiatry; 1976 Jul; 33(7):828-30. PubMed ID: 942286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors].
    von Oefele K; Grohmann R; Hippius H; Rüther E
    Nervenarzt; 1988 Feb; 59(2):118-23. PubMed ID: 3362260
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
    Rosan TA; Mesones HL; Brengio F
    Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of tricyclic antidepressants and monoamine oxidase inhibitors.
    Lader M
    J Clin Psychiatry; 1983 Sep; 44(9 Pt 2):20-4. PubMed ID: 6355073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of the monoamine oxidase inhibitor isocarboxazide in treatment-resistant depression].
    Larsen JK; Krogh-Nielsen L; Brøsen K
    Ugeskr Laeger; 2015 Dec; 177(52):V06150499. PubMed ID: 26692222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
    McGrath PJ; Stewart JW; Nunes EN; Quitkin FM
    J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of depression with isocarboxazide.
    Larsen JK; Rafaelsen OJ
    Acta Psychiatr Scand; 1980 Nov; 62(5):456-63. PubMed ID: 7211430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forms of atypical depression and their response to antidepressant drugs.
    Davidson J; Pelton S
    Psychiatry Res; 1986 Feb; 17(2):87-95. PubMed ID: 3083445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAOIs in the contemporary treatment of depression.
    Thase ME; Trivedi MH; Rush AJ
    Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mania induced by tricyclic-MAOI combination therapy in bipolar treatment-resistant disorder: case reports.
    de la Fuente JR; Berlanga C; León-Andrade C
    J Clin Psychiatry; 1986 Jan; 47(1):40-1. PubMed ID: 3941059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MAO inhibitors and depressive disorders today].
    Bonamy D; Olié JP; Lôo H
    Encephale; 1983; 9(2):123-36. PubMed ID: 6641614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined use of MAOIs and tricyclics.
    White K; Simpson G
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):67-9. PubMed ID: 6376486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative Effectiveness of Monoamine Oxidase Inhibitor and Tricyclic Antidepressant Combination Therapy for Treatment-Resistant Depression.
    Amsterdam JD; Kim TT
    J Clin Psychopharmacol; 2019; 39(6):649-652. PubMed ID: 31688401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combining a classic monoamine oxidase inhibitor with a tricyclic antidepressant in therapy-resistant depression: a case report and literature review].
    Schipper P; Vanmolkot L; Peeters FP
    Tijdschr Psychiatr; 2016; 58(12):886-890. PubMed ID: 27976787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy reviews: tricyclic antidepressant and monoamine oxidase inhibitor combination therapy.
    Ponto LB; Perry PJ; Liskow BI; Seaba HH
    Am J Hosp Pharm; 1977 Sep; 34(9):954-61. PubMed ID: 333909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative effectiveness of tricyclic antidepressant versus monoamine oxidase inhibitor monotherapy for treatment-resistant depression.
    Kim T; Xu C; Amsterdam JD
    J Affect Disord; 2019 May; 250():199-203. PubMed ID: 30861462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricyclic nonresponders: phenomenology and treatment.
    Roose SP; Glassman AH; Walsh BT; Woodring S
    Am J Psychiatry; 1986 Mar; 143(3):345-8. PubMed ID: 3953869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.